Want to see IN:BIOCON full AI Analyst Report?
Biocon Limited (BIOCON) Stock Statistics & Valuation Metrics
Total Valuation
Biocon Limited has a market cap or net worth of INR 573.10B. The enterprise value is INR 828.93B.
- Market Cap
- INR 573.10B
- Enterprise Value
- INR 828.93B
Share Statistics
Biocon Limited has 1,629,694,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,629,694,100
- Owned by Insiders
- ―
- Owned by Institutions
- 4.76%
Financial Efficiency
Biocon Limited’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 2.30%.
- Return on Equity (ROE)
- 0.01
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 2.30%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 10.29M
- Profits Per Employee
- 234.45K
- Employee Count
- 16,447
- Asset Turnover
- 0.27
- Inventory Turnover
- 1.81
Valuation Ratios
The current PE Ratio of Biocon Limited is 103.47. Biocon Limited’s PEG ratio is 18.51.
- PE Ratio
- 103.47
- PS Ratio
- 3.31
- PB Ratio
- 1.62
- Price to FCF
- -996.23
- Price to Operating Cash Flow
- 71.02
- PEG Ratio
- 18.51
Income Statement
In the last 12 months, Biocon Limited had revenue of 169.27B and earned 3.86B in profits. Earnings per share was 2.82.
- Revenue
- 169.27B
- Gross Profit
- 58.85B
- Operating Income
- 14.99B
- Pretax Income
- 4.48B
- Net Income
- 3.86B
- EBITDA
- 33.95B
- Earnings Per Share (EPS)
- 2.82
Cash Flow
In the last 12 months, operating cash flow was 8.03B and capital expenditures -8.61B, giving a free cash flow of -575.00M billion.
- Operating Cash Flow
- 8.03B
- Free Cash Flow
- -575.00M
- Free Cash Flow per Share
- -0.35
Dividends & Yields
Biocon Limited pays an annual dividend of INR 0.50, resulting in a dividend yield of 0.14%
- Dividend Per Share
- INR 0.50
- Dividend Yield
- 0.14%
- Payout Ratio
- 15.80%
- Free Cash Flow Yield
- -0.10%
- Earnings Yield
- 0.87%
Stock Price Statistics
- Beta
- 0.71
- 52-Week Price Change
- -6.63%
- 50-Day Moving Average
- 373.88
- 200-Day Moving Average
- 390.54
- Relative Strength Index (RSI)
- 46.73
- Average Volume (3m)
- 453.58K
Important Dates
Biocon Limited upcoming earnings date is Nov 04, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Nov 04, 2026
- Ex-Dividend Date
- Jul 03, 2026
Financial Position
Biocon Limited as a current ratio of 1.22, with Debt / Equity ratio of 45.35%
- Current Ratio
- 1.22
- Quick Ratio
- 0.79
- Debt to Market Cap
- 0.30
- Net Debt to EBITDA
- 3.61
- Interest Coverage Ratio
- 1.51
Taxes
In the past 12 months, Biocon Limited has paid 791.00M in taxes.
- Income Tax
- 791.00M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Biocon Limited EV to EBITDA ratio is 20.65, with an EV/FCF ratio of -1225.74.
- EV to Sales
- 4.08
- EV to EBITDA
- 20.65
- EV to Free Cash Flow
- -1225.74
- EV to Operating Cash Flow
- 87.73
Balance Sheet
Biocon Limited has INR 28.33B in cash and marketable securities with INR 155.51B in debt, giving a net cash position of -INR 127.18B billion.
- Cash & Marketable Securities
- INR 28.33B
- Total Debt
- INR 155.51B
- Net Cash
- -INR 127.18B
- Net Cash Per Share
- -INR 78.04
- Tangible Book Value Per Share
- INR 53.38
Margins
Gross margin is 42.36%, with operating margin of 8.60%, and net profit margin of 2.86%.
- Gross Margin
- 42.36%
- Operating Margin
- 8.60%
- Pretax Margin
- 2.77%
- Net Profit Margin
- 2.86%
- EBITDA Margin
- 19.74%
- EBIT Margin
- 7.89%
Analyst Forecast
The average price target for Biocon Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 9.83%
- EPS Growth Forecast
- 5.07%
Scores
- Smart Score
- ―
- AI Score
- 49
